Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Ilaris NIS in Korea |
Hereditary Periodic Fever Syndromes, Cryopyrin-associated Periodic Syndromes (CAPS), Colchicine Resistance Familial Mediterranean Fever (crFMF), TNF Receptor Associated Periodic Syndrome (TRAPS), Hyper-IgD Syndrome / Mevalonate Kinase Deficiency (HIDS/MKD), Systemic Juvenile Idiopathic Arthritis (sJIA) | South Korea | NCT06838143 | |
Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia |
Hidradenitis Suppurativa (HS) | Saudi Arabia | NCT06785779 | |
Fabhalta Capsules Specified Drug-use Survey |
C3 Glomerulopathy | Japan | NCT07156149 | |
Real-world Evaluation of Patient Outcomes and Experiences With Ribociclib Early Adopters. |
Breast Cancer | United Kingdom | NCT07243002 | |
Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea) |
Primary Hypercholesterolemia or Mixed Dyslipidemia | South Korea | NCT06770543 | |
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors |
Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer | Phase1, Phase2 | Denmark Germany Italy Japan Singapore Taiwan United States View all |
NCT07288359 |
Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults |
Cryptosporidiosis | Phase2 | United States | NCT07249463 |
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis |
Secondary Progressive Multiple Sclerosis (SPMS) | Phase3 | Argentina Australia Austria Belgium Bulgaria Canada China Colombia Czechia Denmark Estonia France Germany Greece Hungary India Israel Italy Netherlands Poland Portugal Romania Slovakia South Africa Spain Switzerland United Kingdom United States View all |
NCT07225504 |
Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia |
Breast Cancer | Russia | NCT06930859 | |
A Study of DII235 in Adults With Elevated Lipoprotein(a) |
Lipoprotein Disorder | Phase2 | China Germany Japan United States View all |
NCT07235046 |